Friday, July 10, 2026

Drug profile · INN

beclometasone

beclometasone (TRYDONIS) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Respiratory system (R03) R03AL09
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — beclometasone
Class
Respiratory system (R03)
Route
Patents
0
Programs
4
Data quality
0.83

Quick answer

beclometasone (TRYDONIS) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN beclometasone
Brand TRYDONIS
Therapeutic class Respiratory system (R03)
ATC code R03AL09

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. EFC14771 Phase 3 · Sanofi-Aventis U.S · Respiratory tract diseases - Wheezing, Asthma
  2. Beclometasone Phase 2 · United Therapeutics Europe · Asthma
  3. PaNaMa 12782 Approved · Disc Medicine · Episodic expiratory wheezing
  4. Qvar® (beclometasone dipropionate HFA) Approved · Teva Pharma · Asthma

Related & competitor drugs

  1. desloratadine Respiratory system (R01)
  2. deutivacaftor / tezacaftor / vanzacaftor Respiratory system (R07)
  3. ivacaftor Respiratory system (R07)
  4. lumacaftor Respiratory system (R07)
  5. mannitol Respiratory system (R05)
  6. reslizumab Respiratory system (R03)

Frequently asked questions

What is beclometasone?

beclometasone (TRYDONIS) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for beclometasone?

TRYDONIS is a marketed brand name for beclometasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.